Astellas Pharma Inc. (ALPMF)
OTCMKTS · Delayed Price · Currency is USD
9.75
+0.29 (3.07%)
Jul 15, 2025, 4:00 PM EDT
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $17.47 billion as of July 16, 2025. Its market cap has increased by 1.65% in one year.
Market Cap
17.47B
Enterprise Value
22.55B
Revenue
12.77B
Ranking
n/a
PE Ratio
51.56
Stock Price
$9.75
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.47B, an increase of 150.96%. That is a compound annual growth rate of 2.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.00M |
| Glass House Brands | 456.35M |
| CytoDyn | 399.02M |
| Northwest Biotherapeutics | 386.53M |